{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:indapamide",
  "owner": "cardio",
  "kind": "drug",
  "slug": "indapamide",
  "name": "Indapamide",
  "aliases": [],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Indapamide is a thiazide-like diuretic taken by mouth. The US label read is for indapamide tablets and lists two uses: the treatment of hypertension, alone or in combination with other antihypertensive drugs, and the treatment of salt and fluid retention associated with congestive heart failure. No brand-name indapamide label was found in openFDA, so this page rests on a generic manufacturer's label. The label's separate passage on diuretics in pregnancy was not recorded.",
  "summary_technical": "RxNorm ingredient 5764; UNII F089I0511L. MeSH descriptor D007190 is Indapamide. Class: Thiazide-like Diuretic (FDA established pharmacologic class, RxClass). The label read is the indapamide tablets, Rising Pharma Holdings, Inc. label, effective 2023-06-26 in openFDA (application ANDA074461). Other indapamide labels in openFDA, from other sponsors and repackagers, were not read. This page records label indications and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "5764",
      "normalized_value": "5764",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "F089I0511L",
      "normalized_value": "F089I0511L",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D007190",
      "normalized_value": "D007190",
      "match": "exact",
      "version": "read 2026-11-09",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "kidneys"
      ],
      "condition-area": [
        "hypertension",
        "heart-failure"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "fd18e64fc98c979899df809427ca829d29c921ea8394766c35f548e227a22ec1",
  "review": {
    "content_digest": "fd18e64fc98c979899df809427ca829d29c921ea8394766c35f548e227a22ec1",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-indapamide-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:indapamide",
      "category": "descriptive",
      "statement": "The US label of indapamide tablets, in the Rising Pharma Holdings, Inc. version dated 2023-06-26 in openFDA, lists the medicine for the treatment of hypertension, alone or in combination with other antihypertensive drugs, and for the treatment of salt and fluid retention associated with congestive heart failure.",
      "context": {
        "id": "cardio:ctx-fda-indapamide-label-us",
        "label": "People for whom the US label of indapamide tablets lists an indication: hypertension, salt and fluid retention associated with congestive heart failure",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The label does not state an age range in the passages read.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the label passages read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with hypertension",
            "Patients with salt and fluid retention associated with congestive heart failure"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0]",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-indapamide-rising-2026-11-09",
            "retrieved_at": "2026-11-09T13:18:11Z",
            "content_hash": "f5d1e4a29dcccd9463f8c6ba4ab5a58c972367d951fddb28fa5c9bf7b86e3c43",
            "source_effective_date": "2023-06-26",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-indapamide-rising",
            "source_type": "regulator",
            "title": "openFDA drug label record for indapamide tablets, Rising Pharma Holdings, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%220687ed93-4761-4f9c-887d-95309c03f60e%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 0687ed93-4761-4f9c-887d-95309c03f60e (manufacturer Rising Pharma Holdings, Inc., application ANDA074461), returned on 2026-11-09. The label text is dated 2023-06-26 (effective_time). Other openFDA records of indapamide labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb23-openfda-label-indapamide.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20230626.",
          "snapshot": {
            "id": "cardio:openfda-label-indapamide-rising-2026-11-09",
            "retrieved_at": "2026-11-09T13:18:11Z",
            "content_hash": "f5d1e4a29dcccd9463f8c6ba4ab5a58c972367d951fddb28fa5c9bf7b86e3c43",
            "source_effective_date": "2023-06-26",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-indapamide-rising",
            "source_type": "regulator",
            "title": "openFDA drug label record for indapamide tablets, Rising Pharma Holdings, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%220687ed93-4761-4f9c-887d-95309c03f60e%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 0687ed93-4761-4f9c-887d-95309c03f60e (manufacturer Rising Pharma Holdings, Inc., application ANDA074461), returned on 2026-11-09. The label text is dated 2023-06-26 (effective_time). Other openFDA records of indapamide labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb23-openfda-label-indapamide.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "79a44611291e9321aa479e9506f2c966a3657b28ef4fb0b943e60b5f1c79e794",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-indapamide-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Indapamide is a thiazide-like diuretic (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:thiazide-and-thiazide-like-diuretics",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-5764-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-indapamide-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists the treatment of salt and fluid retention associated with congestive heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-indapamide-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01172431",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01172431-2014-06-24",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04455178",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04455178-2021-12-08",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05103332",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05103332-2025-11-03",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda018538",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda018538-2021-03-02",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda219423",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda219423-2026-05-28",
          "locator": "products[0].active_ingredients[1].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/indapamide/",
  "context_path": "api/v1/context/cardio--indapamide.md"
}
